Portal de Periódicos da CAPES

Tongue hyperpigmentation during interferon therapy

2010; Wiley; Volume: 38; Issue: 3 Linguagem: Inglês

10.1111/j.1346-8138.2010.01022.x

1346-8138

Oğuz Karabay, Nadir Göksügür, Aziz Öğütlü,

Herpesvirus Infections and Treatments

The Journal of DermatologyVolume 38, Issue 3 p. 290-291 Tongue hyperpigmentation during interferon therapy Oguz KARABAY, Oguz KARABAY Department of Infectious Disease, Sakarya Research and Education Hospital, SakaryaSearch for more papers by this authorNadir GOKSUGUR, Nadir GOKSUGUR Department of Dermatology, Izzet Baysal Medical Faculty, Izzet Baysal University, Bolu, TurkeySearch for more papers by this authorAziz OGUTLU, Aziz OGUTLU Department of Infectious Disease, Sakarya Research and Education Hospital, SakaryaSearch for more papers by this author Oguz KARABAY, Oguz KARABAY Department of Infectious Disease, Sakarya Research and Education Hospital, SakaryaSearch for more papers by this authorNadir GOKSUGUR, Nadir GOKSUGUR Department of Dermatology, Izzet Baysal Medical Faculty, Izzet Baysal University, Bolu, TurkeySearch for more papers by this authorAziz OGUTLU, Aziz OGUTLU Department of Infectious Disease, Sakarya Research and Education Hospital, SakaryaSearch for more papers by this author First published: 06 October 2010 https://doi.org/10.1111/j.1346-8138.2010.01022.xCitations: 5 Nadir Goksugur, M.D., Izzet Baysal Medical Faculty, Department of Dermatology, 14280 Golkoy, Bolu, Turkey. Email: [email protected] Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Willems M, Munte K, Vrolijk JM et al. Hyperpigmentation during interferon-alpha therapy for chronic hepatitis C virus infection. Br J Dermatol 2003; 149: 390–394. 10.1046/j.1365-2133.2003.05422.x CASPubMedWeb of Science®Google Scholar 2 Goksugur N, Karabay O. Eyelash and eyebrow trichomegaly induced by interferon-alfa 2a. Clin Exp Dermatol 2007; 32: 583–584. 10.1111/j.1365-2230.2007.02454.x CASPubMedWeb of Science®Google Scholar 3 Fernández A, Vázquez S, Rodríguez-González L. Tongue hyperpigmentation resulting from peginterferon alfa-2a and ribavirin treatment in a Caucasian patient with chronic hepatitis C. J Eur Acad Dermatol Venereol 2008; 22: 1389–1391. 10.1111/j.1468-3083.2008.02653.x PubMedWeb of Science®Google Scholar 4 Farshidi D, Chiu MW. Lingual hyperpigmentation from pegylated interferon and ribavirin treatment of hepatitis C. J Am Acad Dermatol 2010; 62: 164–165. 10.1016/j.jaad.2009.03.021 PubMedWeb of Science®Google Scholar 5 de Moraes PC, Noce CW, Thomaz LA et al. Tongue hyperpigmentation resulting from peginterferon alfa and ribavirin combination therapy: a case report. J Am Dent Assoc 2009; 140: 1377–1379. 10.14219/jada.archive.2009.0073 PubMedWeb of Science®Google Scholar 6 Gurguta C, Kauer C, Bergholz U et al. Tongue and skin hyperpigmentation during PEG-interferon-alpha/ribavirin therapy in dark-skinned non-Caucasian patients with chronic hepatitis C. Am J Gastroenterol 2006; 101: 197–198. 10.1111/j.1572-0241.2005.00323.x PubMedWeb of Science®Google Scholar 7 Torres HA, Bull L, Arduino RC, Barnett BJ. Tongue hyperpigmentation in a caucasian patient coinfected with HIV and hepatitis C during peginterferon alfa-2b and ribavirin therapy. Am J Gastroenterol 2007; 102: 1334–1335. 10.1111/j.1572-0241.2007.01162.x PubMedWeb of Science®Google Scholar Citing Literature Volume38, Issue3Special Issue: SPECIAL ISSUE: Severe Adverse Cutaneous Drug Reaction (pages 215‐260)March 2011Pages 290-291 ReferencesRelatedInformation